 Humacyte Inc HUMA has announced results from the first preclinical study of Humacytes small-diameter 3.5mm Human Acellular Vessel HAV in coronary artery bypass grafting CABG. ALERT Matt Maley just released his latest pick with an upside of over 100 in 2 years. 